IC 805 is a potent analgesic and anti-inflammatory compound
It harnesses the power of DENKI technology for post-surgical applications, like pain management after cataract surgery. Its sister compound, IC 800, will be used in chronic cases to alleviate neuropathic pain and pain associated with dry eye.
IC 805 offers a number of benefits:
New non-opioid pain management option in the making
Potential for an effective anti‑inflammatory effect
May be more effective than steroids and NSAIDs
Possible decline in abuse and safety concerns associated with opioid drugs
IPAC’s R&D in action
IC 805 uses our proprietary molecule DENKI to inhibit enzymes that degrade the body’s natural response to pain. DENKI can increase the local concentrations of enkephalins, the opioid peptides produced by the body to relieve pain.